Hematologic malignancies Flashcards

(44 cards)

1
Q

Down Syndrome increases incidence of

A

Leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Benzene is a risk factor of

A

Myelodysplasia and AML

The chemical benzene may be found in glues, adhesives, cleaning products, paint strippers, tobacco smoke and gasoline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Alkylating drugs (Chloramabucil and Melphalan) are a risk factor for

A

AML

Alkylating agents are a class of antineoplastic or anticancer drugs which act by inhibiting the transcription of DNA into RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Etoposide is a risk factor for

A

Secondary leukemia

Translocation of MLL gene at 11q23

Etoposide es usado para tratar el cáncer de células pequeñas de pulmón

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Radiation is a risk factor for

A

Leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Infection is a risk factor for

A

Cancer

Infection is the cause of 18% of cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Viruses are a risk factor for

A

Leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Virus that develops into Burkit lymphoma and Hodgkins lymphoma

A

Epstein Barr (EBV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Kaposi´s sarcoma is the cause of which virus

A

Herpes virus 8 (HV8)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HIV is the cause of which lymphoma

A

CNS lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A maltoma is mainly caused by which bacterial organism

A

H. Pylori

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In patients with EBV, which protozoa causes B. lymphoma

A

Malaria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Gain of function mutations…..

A

Oncogenes

Oncogenes are gain of function mutations in normal cellular genes (Protooncogenes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In which pathway do protooncogenes work

A

Pathways where external signals are transduced to the nucleus to activate genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Most common causes of oncogenes

A

Translocation, mutation or duplication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hematologic malignancies have a higher risk of

Which genetic abnormality?

A

Chromosomal translocations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What do tyrosine kinases do?

A

Phosphorylate protein residues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Talking about tyrosine kinases, mutations in ABL1 causes which hematological malignancy?

A

CML

Chronic myeloid leukemia

19
Q

Talking about tyrosine kinases, mutations in JAK2 causes which hematological malignancy?

A

Myeloproliferative neoplasms

20
Q

Talking about tyrosine kinases, mutations in FLT3 causes which hematological malignancy?

A

AML

Acute myeloid leukemia

21
Q

Talking about tyrosine kinases, mutations in KIT causes which hematological malignancies?

A

System mastocytosis and AML

22
Q

Talking about tyrosine kinases, mutations in Bruton kinase (BTK) causes which hematological malignancy?

23
Q

Loss of function mutations…

A

Tumorr-suppressor genes

24
Q

Most common tumor suppressor gene in cancer

25
TET2 mutations are present in
Myeloid malignancies (20%) | Except CML ## Footnote TET2 mutations are present in 1/5 of healthy elderly patient
26
Speaking of point mutations, the **VAL617Phe** mutation, causes... | Which protein? Which disease?
VAL617Phe mutations in **JAK2** gene leads to activation of JAK2 in **myeloproliferative disease**
27
Speaking of point mutations, **RAS** or **p53** mutations are relevant in
Hematopoietic malignancy
28
Speaking of point mutations in **AML**, 35% of patients have a **frameshift change**, which means...
The nucleophosmin gene has insertion of 4 base pairs
29
In 30% of patients with **AML**, what are their point mutations?
- Internal tandem duplication - Point mutations in FLT-3 gene
30
When speaking about **translocations** in hematologic malignancies, we can have two mechanisms:
1. Fusion of two genes 2. Overexpression of a normal cellular gene ## Footnote Translocations are characteristic of hematologic maignancies
31
Translocation (8:21)
CBF/ETO in AML
32
Translocation (9:22) | Philadelphia gene
BCR-ABL1 in CML
33
Translocation (15:17)
RAR-PML in Acute promyelocytic leukemia (APL)
34
Translocation (12:21)
TEL-AML1 in B-ALL
35
Overexpression of a normal cellular gene (Translocation) almost always involve
TCR or immunoglobulin gene locus
36
Overexpression of Bcl-2 can be seen in
Follicular lymphoma | t (14:18) ## Footnote Bcl-2 es una familia de proteínas formada por alrededor de 25 miembros que regulan procesos de permeabilización mitocondrial y constituyen un punto clave en la vía intrínseca de apoptosis celular.
37
Overexpression of MYC can be seen in
Burkitt lymphoma
38
Deletion in 13q14 can lead to
CLL
39
Loss of multiple chromosomes can lead to
ALL
40
Duplication and amplification is NOT common in hematopoietic malignancies but can involve | Which gene?
MLL gene | mixed-lineage leukemia
41
Epigenetic alterations are specially important in
Myeloid malignancies
42
Examples of epigenetic alterations in myeloid malignancies
- Methylation of cytosine residues in DNA - Acethylation or methylation of histone proteins that package DNA
43
Effect of demethylating agents (Azacytidine)
Increase gene transcription in myelodisplastic syndrome (MDS) and AML
44
Deletion of miR15a/miR16-1 is relevant in
CLL | Including the 13q deletion